20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10028 | PDE4 inhibitor intermediate 1 | Others | |
PDE4 inhibitor intermediate 1 is a PDE4 inhibitor synthesis intermediate. | |||
T27172 | Difamilast | PDE | |
Difamilast is an inhibitor of phosphodiesterase IV. | |||
T7954 | YM976 | PDE | |
YM976 is an orally active PDE4 inhibitor (IC50:2.2 nM) | |||
T25376 | Ensifentrine | Ensifentrina,Ensifentrinum | PDE |
Ensifentrine (Ensifentrinum) is a PDE3/4 inhibitor, although its affinity for PDE3(IC50: 0.4 nM) is 3,440 times higher than that for PDE4(IC50: 1479 nM), that is under clinical development for the treatment of asthma and... | |||
T27475 | GSK356278 | GSK-356278,GSK 356278 | PDE |
GSK356278 is an effective and selective inhibitor of phosphodiesterase 4 (PDE4), with pIC50s of 8.6, 8.8, and 8.7 for human PDE4A, PDE4B, and PDE4D, respectively. GSK356278 has anti-inflammatory, anxiolytic, and cognitio... | |||
T39341 | FCPR03 | PDE | |
FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively. FCPR03 has neuroprotective, anti-inflammatory, and antidepr... | |||
T6445 | Cilomilast | SB-207499,Ariflo | PDE |
Cilomilast (SB-207499) is a potent PDE4 inhibitor with IC50 of about 110 nM, has anti-inflammatory activity and low central nervous system activity. Phase 3. | |||
T6427 | Butein | 2’,3,4,4’-tetrahydroxy Chalcone | Apoptosis , EGFR , Others , PDE , Autophagy |
Butein (2’,3,4,4’-tetrahydroxy Chalcone), a plant polyphenol, is isolated from Rhus verniciflua. It can inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, and also can inhibit EGFR. | |||
T5S2059 | Glaucine | Calcium Channel , Dopamine Receptor , Influenza Virus , Adrenergic Receptor , PDE | |
Glaucine has antitussive, antioxidative potential and antiviral activities, it may be an anti-arthritic agent, it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of h... | |||
T33422 | MK-0873 | MK 0873,MK0873 | PDE |
MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor. | |||
T13448 | (R)-(-)-Rolipram | (R)-Rolipram,(-)-Rolipram | DNA-PK , Others |
(R)-(-)-Rolipram ((-)-Rolipram) is an R-enantiomer of Rolipram which is a PDE4 inhibitor. | |||
T9816 | Arofylline | LAS 31025 | PDE |
Arofylline (LAS 31025) is a PDE4 inhibitor and can be used for asthma studies. | |||
T10316 | AN3199 | Others , PDE | |
AN3199 is a selective inhibitor of PDE4 with an IC50 of 94.5 nM. | |||
T19865 | GEBR-7b | 3-(Cyclopentyloxy)-4-methoxybenzaldehyde | PDE |
GEBR-7b (3-(Cyclopentyloxy)-4-methoxybenzaldehyde) is a phosphodiesterase-4 (PDE4) inhibitor. | |||
T34387 | Ronomilast | ELB353,ELB 353,ELB-353,Elbimilast | |
Ronomilast(Elbimilast, ELB 353) is a PDE4 inhibitor for chronic inflammatory disease. Ronomilast is developed to treat chronic obstructive pulmonary disease (COPD). | |||
T27632 | Isomazole | PDE | |
Isomazole is a novel orally available phosphodiesterase (PDE) inhibitor with calcium-sensitizing properties that inhibits PDE3 and PDE4. | |||
T5101 | BW-A 78U | BW-A78U | PDE |
BW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release. | |||
T22851 | ICI 63197 | 2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one | PDE |
ICI 63197 (2-Amino-6-methyl-4-propyl-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-one) is a PDE4 inhibitor. | |||
T28991 | Tofimilast | CP-325,366,CP-325366,CP325366,CP 325,366,CP 325366 | PDE |
Tofimilast (CP-325366), a PDE4 inhibitor, is used potentially for the treatment of asthma and chronic obstructive pulmonary disease. | |||
T23154 | Piclamilast | RPR 73401,RP 73401 | PDE |
Piclamilast (RP 73401) is a PDE4 inhibitor. |